Breaking News Instant updates and real-time market news.

MASI

Masimo

$91.11

0.26 (0.29%)

08:13
06/19/17
06/19
08:13
06/19/17
08:13

Masimo announces findings from Next Generation SedLine PSi study

Masimo announced the findings of an abstract presented at Euroanaesthesia 2017 in Geneva, Switzerland. In the study, researchers at University Medical Center Groningen, Netherlands, compared original and Next Generation versions of Masimo Patient State Index during Masimo SedLine brain function monitoring of patients under propofol and sevoflurane anesthesia. SedLine brain function monitoring features four simultaneous EEG leads to enable continuous assessment of both sides of the brain, four EEG waveforms, a Density Spectral Array, and PSi. Next Generation SedLine enhances PSi to make it less susceptible to electromyographic interference and to improve its performance in low-power EEG cases. In the study, Dr. Kuizenga and colleagues sought to compare the original and Next Generation PSi algorithms, referred to as PSi-1 and PSi-2, respectively, as they correlated with propofol and sevoflurane drug concentrations and with the Modified Observers Assessment of Alertness and Sedation scale. They also sought to assess the influence of 2 and 4 ng/mL effect-site concentrations of remifentanil on the performance of the two algorithms. The researchers enrolled 36 healthy volunteers, stratified by age, and assigned them randomly to a sequence of four sessions of anesthesia. In one session, propofol was administered in a series of graded steps; in the second, sevoflurane was similarly administered; in the third and fourth, the two concentrations of remifentanil were also administered. During each step of each session, after a twelve-minute delay for equilibration, MOAAS was tested and a blood sample was taken to measure drug concentrations. EEG was collected using Masimo Root with SedLine, from which time-synchronized PSi-1 and PSi-2 values were later extracted. The researchers then plotted MOAAS, drug concentration, PSi-1, and PSi-2 values over time. The researchers found that when charted against drug concentrations, PSi-2 showed "reduced population variability and improved baseline stability" compared to PSi-1. When charted against MOAAS, PSi-2 had "lower interindividual variability" than PSi-1. They also noted that "Both PSis distinguish MOAAS 5, 4, and 3 better during propofol anesthesia compared to sevoflurane. This difference disappears when adding remifentanil." The investigators concluded that "PSi-2 has enhanced signal stability and a better description of the dose-response relationship. PSi-2 has therefore improved capacity as a pharmacodynamic monitor of anesthesia compared to PSi-1." Next Generation SedLine has not received FDA 510(k) clearance and is not available for sale in the U.S.

  • 21

    Jun

  • 22

    Jun

  • 14

    Jul

  • 15

    Aug

MASI Masimo
$91.11

0.26 (0.29%)

05/05/17
ROTH
05/05/17
NO CHANGE
Target $99
ROTH
Buy
Masimo price target lowered to $99 from $104 at Roth Capital
Roth Capital analyst Chris Lewis lowered his price target for Masimo to $99 from $104 noting that the stock was down despite "solid results," and saying he sees the reaction as possibly a "healthy reset" given the stock's run and heightened valuation. The analyst reiterates a Buy rating on the shares.
04/04/17
WEDB
04/04/17
NO CHANGE
WEDB
Masimo price target raised to $100 from $95 at Wedbush
Wedbush analyst Tao Levy raised the estimates on Masimo citing the significant increase in the intensity of this year's flu season versus last year's. The analyst raised the price target on the shares to $100 from $95 and keeps an Outperform rating on the stock.
03/21/17
ROTH
03/21/17
NO CHANGE
Target $104
ROTH
Buy
Masimo price target raised to $104 from $88 at Roth Capital
Roth Capital analyst Chris Lewis raised his price target for Masimo (MASI) to $104 from $88 after hosting a fireside discussion with the company's CEO and Chairman Joe Kiani, and EVP and CFO Mark de Raad. The analyst has a reaffirmed bullish outlook on Masimo, supported by the Philips (PHG) strategic partnership, elevated Core SET growth outlook, new parameter market opportunities, and his expectation for a continued focus on driving "strong earnings growth." He reiterates a Buy rating on Masimo's shares.
03/16/17
PIPR
03/16/17
DOWNGRADE
PIPR
Neutral
Masimo downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst William Quirk downgraded Masimo to Neutral citing valuation with the shares up 146% since the company announced a new CEO compensation package at the beginning of 2016 incentivizing a sale of the company. The analyst believes takeout expectations are justified, but his valuation models suggest limited upside from here. He keeps an $80 price target for the shares.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

, XLI

Industrial Select Sector SPDR

$79.45

-0.24 (-0.30%)

14:49
01/22/18
01/22
14:49
01/22/18
14:49
Technical Analysis
Technical Take: S&P 500 moves to new high, levels to watch »

The S&P 500 (SPX) has…

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

XLI

Industrial Select Sector SPDR

$79.45

-0.24 (-0.30%)

XLB

S&P Select Materials SPDR

$62.93

-0.35 (-0.55%)

XLY

Consumer Discretionary Sector SPDR

$106.28

0.6762 (0.64%)

XLE

Energy Select Sector SPDR

$77.78

1.4 (1.83%)

XLK

Technology Select Sector SPDR

$68.19

0.385 (0.57%)

SPY

SPDR S&P 500 ETF Trust

$281.59

1.181 (0.42%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 18

    Mar

CELG

Celgene

$102.65

0.93 (0.91%)

14:40
01/22/18
01/22
14:40
01/22/18
14:40
Options
Celgene calls outpace puts 3:1 as shares tick modestly higher »

Celgene calls outpace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

14:40
01/22/18
01/22
14:40
01/22/18
14:40
General news
Treasury Action: yields have reversed the earlier declines »

Treasury Action: yields…

GENC

Gencor Industries

14:30
01/22/18
01/22
14:30
01/22/18
14:30
Hot Stocks
Royce & Associates reports 7.37% passive stake in Gencor Industries »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPL

Buckeye Partners

$56.18

1.155 (2.10%)

14:30
01/22/18
01/22
14:30
01/22/18
14:30
Options
Bullish option flow in Buckeye Partners as shares rally »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Feb

CLVS

Clovis

$56.76

0.89 (1.59%)

14:25
01/22/18
01/22
14:25
01/22/18
14:25
Options
Clovis call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Feb

$NSD

NASDAQ Market Internals

14:17
01/22/18
01/22
14:17
01/22/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/22/18
01/22
14:16
01/22/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYBE

Cyberoptics

$17.15

0.45 (2.69%)

14:05
01/22/18
01/22
14:05
01/22/18
14:05
Hot Stocks
Royce & Associates reports 9.64% passive stake in Cyberoptics »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$34.31

0.81 (2.42%)

14:05
01/22/18
01/22
14:05
01/22/18
14:05
Options
FMC Technologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CTB

Cooper Tire

$39.65

-0.7 (-1.73%)

14:04
01/22/18
01/22
14:04
01/22/18
14:04
Hot Stocks
Royce & Associates reports 5.14% passive stake in Cooper Tire »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTG

Computer Task Group

$5.09

0.12 (2.41%)

14:02
01/22/18
01/22
14:02
01/22/18
14:02
Hot Stocks
Breaking Hot Stocks news story on Computer Task Group »

Royce & Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$85.88

18.185 (26.87%)

14:01
01/22/18
01/22
14:01
01/22/18
14:01
Downgrade
Juno Therapeutics rating change  »

Juno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INGR

Ingredion

$140.05

2.92 (2.13%)

13:47
01/22/18
01/22
13:47
01/22/18
13:47
Hot Stocks
Ingredion promotes Anthony DeLio to SVP, corporate strategy »

Ingredion Incorporated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

ADSK

Autodesk

$115.29

2.74 (2.43%)

13:45
01/22/18
01/22
13:45
01/22/18
13:45
Options
Autodesk call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$47.41

-0.86 (-1.78%)

13:44
01/22/18
01/22
13:44
01/22/18
13:44
Hot Stocks
Breaking Hot Stocks news story on Globant »

JP Morgan Chase reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

NWSA

News Corp.

$17.22

0.21 (1.23%)

, NWS

News Corp

$17.55

0.15 (0.86%)

13:39
01/22/18
01/22
13:39
01/22/18
13:39
Hot Stocks
News Corp. chairman Murdoch makes case for carriage fee for trusted publishers »

News Corp. (NWSA) issued…

NWSA

News Corp.

$17.22

0.21 (1.23%)

NWS

News Corp

$17.55

0.15 (0.86%)

FB

Facebook

$181.29

1.49 (0.83%)

GOOG

Alphabet

$1,137.51

7.72 (0.68%)

GOOGL

Alphabet Class A

$1,143.50

7.53 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

  • 18

    Mar

W

Wayfair

$90.98

3.135 (3.57%)

13:35
01/22/18
01/22
13:35
01/22/18
13:35
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

13:35
01/22/18
01/22
13:35
01/22/18
13:35
General news
Treasury Action: yields rebounded towards highs »

Treasury Action: yields…

JNJ

Johnson & Johnson

$147.76

0.4 (0.27%)

, PG

Procter & Gamble

$91.66

0.59 (0.65%)

13:33
01/22/18
01/22
13:33
01/22/18
13:33
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JNJ

Johnson & Johnson

$147.76

0.4 (0.27%)

PG

Procter & Gamble

$91.66

0.59 (0.65%)

VZ

Verizon

$52.87

0.955 (1.84%)

KMB

Kimberly-Clark

$116.54

1.0536 (0.91%)

TRV

Travelers

$137.87

0.02 (0.01%)

FITB

Fifth Third

$32.50

0.33 (1.03%)

HBAN

Huntington Bancshares

$15.81

0.3 (1.93%)

WAT

Waters

$214.03

3.31 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 06

    Feb

  • 13

    Feb

  • 16

    Feb

  • 08

    Mar

NFLX

Netflix

$220.46

0.13 (0.06%)

, AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

13:32
01/22/18
01/22
13:32
01/22/18
13:32
Earnings
Notable companies reporting after market close »

Notable companies…

NFLX

Netflix

$220.46

0.13 (0.06%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

RMD

ResMed

$88.10

-0.58 (-0.65%)

STLD

Steel Dynamics

$46.42

0.16 (0.35%)

ZION

Zions Bancorp

$53.73

0.87 (1.65%)

BRO

Brown & Brown

$52.13

-0.375 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 16

    Feb

JEC

Jacobs Engineering

$70.29

0.34 (0.49%)

, VMC

Vulcan Materials

$133.37

-1.66 (-1.23%)

13:29
01/22/18
01/22
13:29
01/22/18
13:29
Periodicals
Axios obtains draft of White House infrastructure plan »

Jonathan Swan of Axios…

JEC

Jacobs Engineering

$70.29

0.34 (0.49%)

VMC

Vulcan Materials

$133.37

-1.66 (-1.23%)

PWR

Quanta Services

$39.03

0.04 (0.10%)

EXP

Eagle Materials

$116.71

-0.3099 (-0.26%)

FLR

Fluor

$61.14

0.71 (1.17%)

USCR

U.S. Concrete

$78.90

0.65 (0.83%)

ACM

Aecom

$39.12

-0.09 (-0.23%)

CBI

CB&I

$19.16

0.19 (1.00%)

GVA

Granite Construction

$67.14

-0.5 (-0.74%)

CAT

Caterpillar

$170.34

-0.07 (-0.04%)

MLM

Martin Marietta

$226.08

-0.9 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 31

    Jan

  • 06

    Feb

  • 07

    Feb

  • 20

    Feb

  • 14

    Mar

FTR

Frontier Communications

$7.77

0.56 (7.77%)

13:25
01/22/18
01/22
13:25
01/22/18
13:25
Options
Frontier Communications call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

FE

FirstEnergy

$33.24

3.835 (13.04%)

13:25
01/22/18
01/22
13:25
01/22/18
13:25
Conference/Events
FirstEnergy participates in a webcast with Wolfe Research »

Utilities Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

SANM

Sanmina

$35.45

0.5 (1.43%)

, FNSR

Finisar

$20.68

0.26 (1.27%)

13:22
01/22/18
01/22
13:22
01/22/18
13:22
Hot Stocks
Optical equipment makers fall after Sanmina pre-announcement »

Shares of tech companies…

SANM

Sanmina

$35.45

0.5 (1.43%)

FNSR

Finisar

$20.68

0.26 (1.27%)

OCLR

Oclaro

$6.77

0.06 (0.89%)

LITE

Lumentum

$48.85

-2.85 (-5.51%)

VIAV

Viavi

$8.80

-0.14 (-1.57%)

CIEN

Ciena

$21.83

-0.02 (-0.09%)

AAOI

Applied Optoelectronics

$35.03

2.24 (6.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

  • 01

    Feb

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

  • 21

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.